Opinions of Czech general practitioners on generic drugs and substitution

被引:5
|
作者
Dosedel, Martin [1 ]
Maly, Josef [1 ]
Kubena, Ales [1 ]
Vlcek, Jiri [1 ]
机构
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Social & Clin Pharm, Hradec Kralove 50005, Czech Republic
来源
关键词
General practitioner; Brand name drug; Generic drug; Generic substitution; PHYSICIANS OPINIONS; BIOEQUIVALENCE; PRESCRIBERS; EXPERIENCES; BEHAVIOR; DISEASE;
D O I
10.2478/s11536-013-0344-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to map and analyze general practitioners` opinions of, attitudes towards and experiences with generic drugs and generic substitution (GS) in the Czech Republic. General practitioners (GPs) who took part in the annual and regional professional conferences of the Society of General Practice in the period from November 2008 until March 2009 were asked to complete the 28-item questionnaire concerning the issue of generic drugs and GS. Questions were organized in 5 sections aimed at assessing the attitude towards GS, understanding the legislation and opinions on statements related to GS. All data were analyzed using descriptive statistics and correlations were tested by selected parametric and non-parametric tests. Total of 263 completed questionnaires were returned (mean age of 52.2 years (SD=13.7), 177 (67.3%) females and 248 (94.3%) GPs having a practice specialization). 99 (37.6%) respondents have considered generic drugs to be bioequivalent to the respective brand name drugs. 121 (46.0%) respondents believed that generic drugs are of lower quality than brand name drugs. None of respondent showed acquaintance with all the legal rules for GS. Awareness of the legislation and attitude towards GS correlated with the age (p < 0.001). In conclusion, distrust among GPs in generic drugs derives from poor knowledge and personal experiences.
引用
收藏
页码:830 / 838
页数:9
相关论文
共 50 条
  • [41] New Zealand general practitioners' opinions of the polypill concept
    Holt, Shaun
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2009, 122 (1294) : 116 - 117
  • [42] EXPERIENCES IN GENERIC SUBSTITUTION OF ANTIEPILEPTIC DRUGS IN TAIWAN
    Hsieh, L.
    Tsai, J.
    Yu, H.
    Chi, J.
    [J]. EPILEPSIA, 2009, 50 : 97 - 97
  • [43] Generic substitution of anti-arrhythmic drugs
    Jardine, RM
    Milne, DA
    Obel, IWP
    Okreglicki, A
    Richards, B
    Scott-Millar, RN
    Sweidan, D
    Thornton, A
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2001, 91 (10): : 785 - 785
  • [44] GENERIC SUBSTITUTION OF PRESCRIPTION DRUGS - A CONSUMER DILEMMA
    WARD, W
    [J]. ASSOCIATION OF FOOD & DRUG OFFICIALS QUARTERLY BULLETIN, 1981, 45 (03): : 146 - 153
  • [45] Clarification Regarding Generic Substitution for Psychotropic Drugs
    Blier, Pierre
    [J]. CNS SPECTRUMS, 2009, 14 (12) : 709 - 710
  • [46] Generic Substitution of Antiepileptic Drugs: A Telephone Survey
    Yamada, Mikiko
    Welty, Timothy E.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 938 - 939
  • [47] EPILEPSY Generic substitution: are antiepileptic drugs different?
    Bazil, Carl W.
    [J]. NATURE REVIEWS NEUROLOGY, 2009, 5 (11) : 587 - 588
  • [48] Strategies of collaboration between general practitioners and psychiatrists:: A survey of practitioners' opinions and characteristics
    Lucena, RJM
    Lesage, A
    Élie, R
    Lamontagne, Y
    Corbière, M
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (08): : 750 - 758
  • [49] GENERAL PRACTITIONERS INDICATIONS FOR PSYCHOTROPIC DRUGS
    HEMMINKI, E
    [J]. SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE, 1974, 2 (02): : 79 - 85
  • [50] Prescriptive variability of drugs by general practitioners
    Bucholc, Magda
    O'Kane, Maurice
    Ashe, Siobhan
    Wong-Lin, KongFatt
    [J]. PLOS ONE, 2018, 13 (02):